SCHEDULE 13G: Goldman Sachs Discloses 6.8% Stake in Cross Country Healthcare
Beneficial Ownership Disclosure
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.8% in Cross Country Healthcare, Inc. common stock.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, have filed a Schedule 13G, indicating their beneficial ownership in Cross Country Healthcare, Inc.
- As of March 31, 2025, the reporting persons collectively beneficially own 2,242,279.43 shares of Cross Country Healthcare, Inc. Common Stock.
- This aggregate amount represents 6.8% of the issuer's class of securities.
- The filing indicates that Goldman Sachs holds shared voting power over 2,241,857.43 shares and shared dispositive power over 2,242,279.43 shares, with no sole voting or dispositive power.
- The securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain subjective language or performance metrics that would indicate a strong positive or negative sentiment. It is neutral in tone.
Positives
- A significant stake by a major financial institution like Goldman Sachs could be viewed as a vote of confidence in Cross Country Healthcare, Inc.'s prospects.
Future Outlook
NA
Industry Context
This filing indicates a significant institutional investment by Goldman Sachs in the healthcare staffing sector, represented by Cross Country Healthcare, Inc. Such investments by major financial players can signal confidence in the long-term prospects of the industry or specific companies within it, potentially driven by demographic trends, healthcare demand, or labor market dynamics.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a prominent institutional investor like Goldman Sachs could be perceived positively, potentially boosting investor confidence.
Key Dates
| Date | Description |
|---|---|
| 2023-12-01 | Previous Power of Attorney granted by Goldman Sachs & Co. LLC superseded. |
| 2024-02-09 | Previous Power of Attorney granted by The Goldman Sachs Group, Inc. superseded. |
| 2024-07-29 | Date of signing of Power of Attorney for The Goldman Sachs Group, Inc., effective until July 29, 2025. |
| 2024-10-01 | Date of signing of Power of Attorney for Goldman Sachs & Co. LLC, effective until October 1, 2025. |
| 2025-03-31 | Date of event which requires the filing of this statement (beneficial ownership threshold reached/maintained). |
| 2025-04-02 | Date of filing of the Schedule 13G and Joint Filing Agreement. |
| 2025-07-29 | Expiration date of the Power of Attorney for The Goldman Sachs Group, Inc. |
| 2025-10-01 | Expiration date of the Power of Attorney for Goldman Sachs & Co. LLC. |
Keywords
Goldman Sachs, Cross Country Healthcare, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Institutional Investor, Healthcare Staffing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.